← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AJENAT PHARMS · Approved 2016-03-14

Drug application

FDA Application #

ANDA091286

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

AJENAT PHARMS

Manufacturer

Ajenat Pharmaceuticals LLC

First approval

2016-03-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown